Related Experiment Video
Updated: Apr 30, 2026
09:06
Growth Assays to Assess Polyglutamine Toxicity in Yeast
Published on: March 5, 2012
13.1K
Polyglutamine (PolyQ) diseases: genetics to treatments
Hueng-Chuen Fan1, Li-Ing Ho, Ching-Shiang Chi
1Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Cell Transplantation
|May 13, 2014
Summary
Polyglutamine (polyQ) diseases stem from expanded CAG repeats, causing neurodegeneration with no cure. Stem cell transplantation offers a promising therapeutic strategy for these debilitating conditions.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Polyglutamine (polyQ) diseases are a class of neurodegenerative disorders.
- These diseases result from expanded cytosine-adenine-guanine (CAG) trinucleotide repeats within specific genes.
- Nine distinct polyQ disorders, including spinocerebellar ataxias (SCA) and Huntington's disease (HD), are recognized.
Purpose of the Study:
- To review the current understanding of polyglutamine diseases.
- To explore existing therapeutic limitations and future directions.
- To highlight the potential of cellular transplantation as a novel treatment.
Main Methods:
- Review of existing literature on polyglutamine diseases.
- Analysis of current treatment strategies and their efficacy.
- Evaluation of stem cell transplantation as a therapeutic approach.
Main Results:
- PolyQ diseases are characterized by protein aggregation in neurons, leading to dysfunction and degeneration.
- Current treatments are largely symptomatic, with limited long-term efficacy.
- Pharmacological treatments face challenges with complications and waning effectiveness.
Conclusions:
- Despite advances, polyQ diseases remain incurable and largely untreatable.
- Stem cell transplantation presents a promising avenue for neuronal repair and functional restoration.
- Further research into stem cell therapies is crucial for developing effective treatments for polyQ diseases.
More Related Videos
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
4.5K
06:49Monitoring Protein Aggregation Kinetics In Vivo using Automated Inclusion Counting in Caenorhabditis elegans
Published on: December 17, 2021
5.1K
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
120
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
120
01:31Translation
133.5K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
133.5K
01:31Translation
16.8K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
16.8K
01:21Huntington Disease l: Introduction
98
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
98
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
93
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
93
01:27Principles of Pharmacogenetics: Types of Genetic Variants
137
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
137